Renaissance Technologies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $161M | Buy |
|
|||||
2025
Q1 | $127M | Buy |
|
|||||
2024
Q4 | $60M | Buy |
|
|||||
2024
Q3 | $47M | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $125M | Buy |
|
|||||
2023
Q3 | $59.7M | Sell |
|
|||||
2023
Q2 | $77.3M | Buy |
|
|||||
2023
Q1 | $79.3M | Buy |
|
|||||
2022
Q4 | $47.3M | Buy |
|
|||||
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $63.3M | Sell |
|
|||||
2022
Q1 | $192M | Sell |
|
|||||
2021
Q4 | $314M | Sell |
|
|||||
2021
Q3 | $421M | Sell |
|
|||||
2021
Q2 | $488M | Buy |
|
|||||
2021
Q1 | $440M | Sell |
|
|||||
2020
Q4 | $1.15B | Sell |
|
|||||
2020
Q3 | $1.84B | Sell |
|
|||||
2020
Q2 | $2.56B | Sell |
|
|||||
2020
Q1 | $3.68B | Buy |
|
|||||
2019
Q4 | $3.86B | Buy |
|
|||||
2019
Q3 | $1.66B | Buy |
|
|||||
2019
Q2 | $939M | Buy |
|
|||||
2019
Q1 | $589M | Buy |
|
|||||
2018
Q4 | $361M | Sell |
|
|||||
2018
Q3 | $580M | Sell |
|
|||||
2018
Q2 | $584M | Sell |
|
|||||
2018
Q1 | $919M | Buy |
|
|||||
2017
Q4 | $876M | Buy |
|
|||||
2017
Q3 | $691M | Sell |
|
|||||
2017
Q2 | $752M | Buy |
|
|||||
2017
Q1 | $352M | Buy |
|
|||||
2016
Q4 | $34.9M | Sell |
|
|||||
2016
Q3 | $256M | Buy |
|
|||||
2016
Q2 | $39.5M | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $30.6M | Buy |
|
|||||
2014
Q4 | $17.6M | Buy |
|
|||||
2014
Q3 | $13.9M | Sell |
|
|||||
2014
Q2 | $119M | Buy |
|
|||||
2014
Q1 | $77.5M | Buy |
|
|||||
2013
Q4 | $2.19M | Sell |
|
|||||
2013
Q3 | $201M | Sell |
|
|||||
2013
Q2 | $381M | Buy |
|